Drug safety alert: IPC flags adverse reactions linked to rheumatoid arthritis drug Piroxicam - Video
Overview
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of September ,has revealed that Piroxicam, a non-steroidal anti-inflammatory agent (NSAID) which is used to treat the symptoms of osteoarthritis and rheumatoid arthritis, is linked with Adverse Drug Reactions (ADRs) named Fixed Drug Eruption.
This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.
Piroxicam is in a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Piroxicam works by reducing hormones that cause inflammation and pain in the body. Piroxicam is used to reduce the pain, inflammation, and stiffness caused by rheumatoid arthritis and osteoarthritis.
For more details, check out the link given below:
Drug Safety Alert: IPC Flags Adverse Reactions Linked To Rheumatoid Arthritis Drug Piroxicam
Speakers
